{"product_id":"angiodynamics","title":"AngioDynamics: Six Analyses of Sourcing and Production Capacity","description":"\u003cdiv class=\"pb-bundle\" data-pestel-bundle=\"v1\"\u003e\n\u003cdiv class=\"pb-intro\"\u003e\n\u003cp class=\"pb-eyebrow\"\u003e2026 company context · Six strategic perspectives\u003c\/p\u003e\n\u003ch2 class=\"pb-title\"\u003eAngioDynamics Strategy Analysis Bundle\u003c\/h2\u003e\n\u003cp class=\"pb-lead\"\u003eAngioDynamics is the display name for AngioDynamics, Inc., an SEC-reporting business classified in surgical and medical instruments and apparatus. The supplied product context relates to medical-device activity in vascular and oncology applications, where sterile manufacturing, precision components, clinical evidence and reliable procedural supply can affect clinician confidence and institutional adoption.\u003c\/p\u003e\n\u003cp class=\"pb-lead\"\u003eIn its \u003ca href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1275187\/000162828026048138\/\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eForm 10-K filed July 14, 2026\u003c\/a\u003e, AngioDynamics, Inc. reported revenue of USD 320.174 million and a GAAP net loss of USD 36.742 million for the period from June 1, 2025 to May 31, 2026. These figures help frame portfolio, cost structure and market-access questions; they are company-context evidence, not proof that the downloadable files were updated in 2026.\u003c\/p\u003e\n\u003cdiv class=\"pb-formats\"\u003e\n\u003cspan class=\"pb-format\"\u003e\u003cspan class=\"pb-file-icon pb-file-icon--excel\" aria-hidden=\"true\"\u003e\u003c\/span\u003eExcel files with structured analysis frameworks\u003c\/span\u003e\u003cspan class=\"pb-format\"\u003e\u003cspan class=\"pb-file-icon pb-file-icon--word\" aria-hidden=\"true\"\u003e\u003c\/span\u003eWord files with detailed company analysis\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cp class=\"pb-note\"\u003e\u003cstrong\u003eAbout the images:\u003c\/strong\u003e Each image is a brief summary preview. Your purchase includes the Excel frameworks and Word files with the detailed company analysis. The previews are not the complete downloadable products.\u003c\/p\u003e\n\u003cnav class=\"pb-nav\" aria-label=\"Explore the six analyses\"\u003e\u003ca href=\"#bcg\"\u003eBCG Matrix\u003c\/a\u003e\u003ca href=\"#canvas\"\u003eCanvas\u003c\/a\u003e\u003ca href=\"#five-forces\"\u003eFive Forces\u003c\/a\u003e\u003ca href=\"#marketing-mix\"\u003eMarketing Mix\u003c\/a\u003e\u003ca href=\"#pestel\"\u003ePESTLE\u003c\/a\u003e\u003ca href=\"#swot\"\u003eSWOT Analysis\u003c\/a\u003e\u003c\/nav\u003e\n\u003c\/div\u003e\n\n\u003cdiv id=\"bcg\" class=\"pb-row\" tabindex=\"-1\" aria-labelledby=\"pb-heading-bcg\"\u003e\n\u003cdiv class=\"pb-copy\"\u003e\n\u003cdiv class=\"pb-heading\"\u003e\n\u003cspan class=\"pb-icon pb-icon--bcg\" aria-hidden=\"true\"\u003e\u003c\/span\u003e\u003ch3 id=\"pb-heading-bcg\" class=\"pb-heading-title\"\u003eBCG Matrix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp class=\"pb-question\"\u003eWhich AngioDynamics offerings deserve investment, harvesting discipline or closer validation as their markets develop?\u003c\/p\u003e\n\u003cp\u003eAn AngioDynamics BCG Matrix helps organise a medical-device portfolio around two distinct measures: market growth and relative market share. It provides a structured way to compare possible Stars, Cash Cows, Question Marks and Dogs without assuming that any vascular or oncology offering already belongs in a particular quadrant. That distinction matters where clinical adoption, evidence requirements, manufacturing readiness and reimbursement conditions can make a growing category costly to serve before it becomes commercially established.\u003c\/p\u003e\n\u003cul class=\"pb-list\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePortfolio logic.\u003c\/strong\u003e Compare procedure demand, competitive position and resource needs across relevant product lines rather than treating all device opportunities as equally attractive.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCapital trade-offs.\u003c\/strong\u003e Examine where clinical education, production capacity or evidence development could require funding, and where mature demand may support cash generation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWorking view.\u003c\/strong\u003e Use the Excel framework to map assumptions and comparisons, then use the Word analysis to interpret the strategic questions behind each possible placement.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"pb-outcome\"\u003e\n\u003cstrong\u003eWhat you can take away\u003c\/strong\u003e a clearer basis for discussing portfolio priorities, evidence needs and the conditions that would justify changing resource allocation.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pb-visual\"\u003e\n\u003cspan data-pestel-preview=\"1\"\u003e\u003c\/span\u003e\u003cp class=\"pb-caption\"\u003eBCG Matrix summary preview. The full company analysis is provided in Excel and Word.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv id=\"canvas\" class=\"pb-row pb-row--reverse\" tabindex=\"-1\" aria-labelledby=\"pb-heading-canvas\"\u003e\n\u003cdiv class=\"pb-copy\"\u003e\n\u003cdiv class=\"pb-heading\"\u003e\n\u003cspan class=\"pb-icon pb-icon--canvas\" aria-hidden=\"true\"\u003e\u003c\/span\u003e\u003ch3 id=\"pb-heading-canvas\" class=\"pb-heading-title\"\u003eBusiness Model Canvas\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp class=\"pb-question\"\u003eHow do clinical value, institutional purchasing and regulated delivery connect to AngioDynamics' economics?\u003c\/p\u003e\n\u003cp\u003eThe AngioDynamics Business Model Canvas brings together all nine building blocks: customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partnerships and cost structure. For a business serving vascular and oncology procedures, the framework helps connect clinician and provider needs with product availability, clinical support, specialised production and the economic work required to deliver devices reliably. It is useful for testing whether a proposed growth path reinforces the whole model rather than improving one activity while creating pressure elsewhere.\u003c\/p\u003e\n\u003cul class=\"pb-list\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eCare-pathway fit.\u003c\/strong\u003e Examine how device performance, safety evidence and procedural workflow may shape the value offered to clinicians, care providers and purchasing stakeholders.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOperating backbone.\u003c\/strong\u003e Consider the links among specialised components, sterile production, quality activities, supplier relationships and the costs needed to sustain service.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel connections.\u003c\/strong\u003e Populate the Excel canvas as a shared working map, then use the Word analysis to explore dependencies and strategic tensions in more depth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"pb-outcome\"\u003e\n\u003cstrong\u003eWhat you can take away\u003c\/strong\u003e a connected view of how value delivery, revenue logic and operating requirements should be considered together.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pb-visual\"\u003e\n\u003cspan data-pestel-preview=\"2\"\u003e\u003c\/span\u003e\u003cp class=\"pb-caption\"\u003eBusiness Model Canvas summary preview. The full company analysis is provided in Excel and Word.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv id=\"five-forces\" class=\"pb-row\" tabindex=\"-1\" aria-labelledby=\"pb-heading-five-forces\"\u003e\n\u003cdiv class=\"pb-copy\"\u003e\n\u003cdiv class=\"pb-heading\"\u003e\n\u003cspan class=\"pb-icon pb-icon--five-forces\" aria-hidden=\"true\"\u003e\u003c\/span\u003e\u003ch3 id=\"pb-heading-five-forces\" class=\"pb-heading-title\"\u003ePorter's Five Forces\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp class=\"pb-question\"\u003eWhat industry pressures can influence margins and adoption in the medical-device markets AngioDynamics serves?\u003c\/p\u003e\n\u003cp\u003eAngioDynamics Porter's Five Forces analysis examines rivalry, supplier power, buyer power, threat of new entrants and threat of substitutes around the relevant medical-device setting. Rivalry can involve differentiated procedure solutions and clinical proof, while supplier power may matter for specialised catheters, components and manufacturing inputs. Buyer power can arise through hospital procurement and care-provider evaluation. New entrants face technical and regulatory hurdles, yet substitute pressure may also come from alternative procedures or treatment approaches that meet a similar clinical need.\u003c\/p\u003e\n\u003cul class=\"pb-list\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupply exposure.\u003c\/strong\u003e Assess how qualification requirements, single-source risk and specialised inputs could affect continuity, cost and flexibility during product ramps.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAccess conditions.\u003c\/strong\u003e Compare the influence of clinical users, value-analysis processes and institutional procurement on adoption and commercial negotiations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForce comparison.\u003c\/strong\u003e Use the Excel framework to record evidence and assumptions for each force, alongside the Word analysis for a more reasoned view of implications.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"pb-outcome\"\u003e\n\u003cstrong\u003eWhat you can take away\u003c\/strong\u003e a disciplined industry-pressure map that distinguishes direct competition from purchasing, supply and substitution risks.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pb-visual\"\u003e\n\u003cspan data-pestel-preview=\"3\"\u003e\u003c\/span\u003e\u003cp class=\"pb-caption\"\u003ePorter's Five Forces summary preview. The full company analysis is provided in Excel and Word.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv id=\"marketing-mix\" class=\"pb-row pb-row--reverse\" tabindex=\"-1\" aria-labelledby=\"pb-heading-marketing-mix\"\u003e\n\u003cdiv class=\"pb-copy\"\u003e\n\u003cdiv class=\"pb-heading\"\u003e\n\u003cspan class=\"pb-icon pb-icon--marketing-mix\" aria-hidden=\"true\"\u003e\u003c\/span\u003e\u003ch3 id=\"pb-heading-marketing-mix\" class=\"pb-heading-title\"\u003eMarketing Mix (4Ps)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp class=\"pb-question\"\u003eHow can product, price, place and promotion be examined for complex medical-device buying decisions?\u003c\/p\u003e\n\u003cp\u003eAn AngioDynamics Marketing Mix analysis applies Product, Price, Place and Promotion to a regulated, institutionally purchased medical-device context. Product analysis can consider procedural utility, supporting evidence and dependable performance. Price prompts questions about the economic case for providers rather than unsupported list-price claims. Place considers routes through clinical and procurement environments, including the service needed to make products available for procedures. Promotion focuses on scientifically appropriate education, peer-reviewed evidence and communication that can support informed clinical evaluation.\u003c\/p\u003e\n\u003cul class=\"pb-list\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eOffering proposition.\u003c\/strong\u003e Explore how device features, clinical evidence and workflow relevance can be communicated without separating marketing claims from substantiation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommercial route.\u003c\/strong\u003e Assess the relationship between provider purchasing processes, supply reliability, field support and the economics of access to target accounts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAction planning.\u003c\/strong\u003e Use the Excel structure to compare 4Ps choices by customer need, then refer to the Word analysis when developing a coherent discussion of trade-offs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"pb-outcome\"\u003e\n\u003cstrong\u003eWhat you can take away\u003c\/strong\u003e a practical way to align commercial choices with clinical decision-making, procurement realities and evidence-led communication.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pb-visual\"\u003e\n\u003cspan data-pestel-preview=\"4\"\u003e\u003c\/span\u003e\u003cp class=\"pb-caption\"\u003eMarketing Mix summary preview. The full company analysis is provided in Excel and Word.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv id=\"pestel\" class=\"pb-row\" tabindex=\"-1\" aria-labelledby=\"pb-heading-pestel\"\u003e\n\u003cdiv class=\"pb-copy\"\u003e\n\u003cdiv class=\"pb-heading\"\u003e\n\u003cspan class=\"pb-icon pb-icon--pestel\" aria-hidden=\"true\"\u003e\u003c\/span\u003e\u003ch3 id=\"pb-heading-pestel\" class=\"pb-heading-title\"\u003ePESTLE Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp class=\"pb-question\"\u003eWhich external changes could reshape the conditions for developing, supplying and adopting AngioDynamics devices?\u003c\/p\u003e\n\u003cp\u003eAn AngioDynamics PESTLE analysis, also commonly called PESTEL, separates Political, Economic, Social, Technological, Legal and Environmental influences. It helps distinguish a question to monitor from a documented change. Relevant topics may include public-health priorities, provider budget pressure, demographic and care-delivery trends, advances in procedure technology, product-quality and regulatory obligations, and environmental expectations around manufacturing, materials and waste. This outward-looking lens is useful because clinical demand alone does not determine whether a device can be developed, supplied and adopted effectively.\u003c\/p\u003e\n\u003cul class=\"pb-list\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePolicy and legal context.\u003c\/strong\u003e Identify questions around medical-device oversight, reimbursement environments and quality obligations without assuming a specific new law or policy outcome.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTechnology horizon.\u003c\/strong\u003e Compare how procedural innovation, evidence expectations and manufacturing technology could create opportunities or increase investment requirements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring agenda.\u003c\/strong\u003e Use the Excel framework to assign external signals for review, with the Word analysis providing context for why each factor may matter.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"pb-outcome\"\u003e\n\u003cstrong\u003eWhat you can take away\u003c\/strong\u003e an external watchlist that can support more informed scenario discussions across market access, operations and product planning.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pb-visual\"\u003e\n\u003cspan data-pestel-preview=\"5\"\u003e\u003c\/span\u003e\u003cp class=\"pb-caption\"\u003ePESTLE Analysis summary preview. The full company analysis is provided in Excel and Word.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv id=\"swot\" class=\"pb-row pb-row--reverse\" tabindex=\"-1\" aria-labelledby=\"pb-heading-swot\"\u003e\n\u003cdiv class=\"pb-copy\"\u003e\n\u003cdiv class=\"pb-heading\"\u003e\n\u003cspan class=\"pb-icon pb-icon--swot\" aria-hidden=\"true\"\u003e\u003c\/span\u003e\u003ch3 id=\"pb-heading-swot\" class=\"pb-heading-title\"\u003eSWOT Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp class=\"pb-question\"\u003eHow can AngioDynamics connect internal capabilities and constraints with changing external opportunities and threats?\u003c\/p\u003e\n\u003cp\u003eAn AngioDynamics SWOT analysis separates internal Strengths and Weaknesses from external Opportunities and Threats. The framework can help teams examine whether capabilities such as specialised manufacturing, clinical evidence development or procedural knowledge represent potential strengths, while also considering internal constraints such as complexity, cost pressure or capacity demands. Opportunities and threats should be considered outside the company: changing care needs, technology shifts, procurement conditions, supply disruption and regulatory expectations. Keeping these categories separate makes the resulting discussion more useful than a simple list of positives and negatives.\u003c\/p\u003e\n\u003cul class=\"pb-list\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eInternal reality.\u003c\/strong\u003e Evaluate capabilities, resources and operating constraints that may affect execution in vascular and oncology-focused device markets.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExternal fit.\u003c\/strong\u003e Relate possible market openings and industry risks to the external conditions highlighted through the Five Forces and PESTLE lenses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePriority synthesis.\u003c\/strong\u003e Use the Excel matrix to organise candidate issues, then use the Word analysis to test how combinations of factors could shape strategic choices.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"pb-outcome\"\u003e\n\u003cstrong\u003eWhat you can take away\u003c\/strong\u003e a balanced discussion tool for linking operational capabilities with market conditions instead of treating either in isolation.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pb-visual\"\u003e\n\u003cspan data-pestel-preview=\"6\"\u003e\u003c\/span\u003e\u003cp class=\"pb-caption\"\u003eSWOT Analysis summary preview. The full company analysis is provided in Excel and Word.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"pb-closing\"\u003e\n\u003ch3\u003eConnect portfolio choices to the conditions behind them\u003c\/h3\u003e\n\u003cp\u003eUsed together, the six perspectives help turn an AngioDynamics portfolio discussion into a fuller view of business-model economics, industry pressure, commercial choices, external change and execution capability. The Excel frameworks provide organised places to compare inputs and assumptions, while the detailed Word analyses support a more considered interpretation of the strategic questions.\u003c\/p\u003e\n\u003cp class=\"pb-source\"\u003e\u003cstrong\u003eCompany background:\u003c\/strong\u003e \u003ca href=\"https:\/\/data.sec.gov\/submissions\/CIK0001275187.json\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eAngioDynamics — SEC issuer submissions profile\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PESTEL Analysis","offers":[{"title":"Default Title","offer_id":58097801134428,"sku":"angiodynamics-pestle-analysis","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0938\/8127\/0620\/files\/angiodynamics.webp?v=1790945898","url":"https:\/\/pestel-analysis.com\/products\/angiodynamics","provider":"PESTEL ANALYSIS","version":"1.0","type":"link"}